sodium selenite has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menon, M; Thamilselvan, S; Thamilselvan, V | 1 |
1 other study(ies) available for sodium selenite and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carmustine; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Molecular Targeted Therapy; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Signal Transduction; Sodium Selenite; Xenograft Model Antitumor Assays | 2016 |